Last $6.14 USD
Change Today +0.198 / 3.33%
Volume 264.0
MSON On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

misonix inc (MSON) Snapshot

Open
$6.14
Previous Close
$5.94
Day High
$6.14
Day Low
$6.14
52 Week High
02/7/14 - $7.17
52 Week Low
11/8/13 - $3.86
Market Cap
44.4M
Average Volume 10 Days
5.6K
EPS TTM
$-0.38
Shares Outstanding
7.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MISONIX INC (MSON)

Related News

No related news articles were found.

misonix inc (MSON) Related Businessweek News

No Related Businessweek News Found

misonix inc (MSON) Details

Misonix, Inc. designs, develops, manufactures, and markets minimally invasive ultrasonic surgical device products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical applications. The company offers BoneScalpel cutting system, which is used for surgical procedures of the spine and on maxillofacial procedures; SonaStar surgical aspirator that is used to emulsify and remove soft and hard tumors; and SonicOne wound cleansing and debridement system for the removal of devitalized tissue and fibrin deposits while sparing viable cells. It also markets AutoSonix ultrasound cutting and coagulating system; and Lysonix ultrasound assisted liposuction device. The company sells its products through independent direct sales persons, sales agents, and distributors. It has operations in the United States, Australia, Europe, Asia, Canada, Mexico, South America, South Africa, and the Middle East. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

71 Employees
Last Reported Date: 09/24/13
Founded in 1959

misonix inc (MSON) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $388.9K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $243.1K
Vice President of Research & Development and ...
Total Annual Compensation: $176.0K
Compensation as of Fiscal Year 2013.

misonix inc (MSON) Key Developments

Misonix Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2013

Misonix Inc. reported unaudited consolidated earnings results for the second quarter and six months ended December 31, 2013. For the quarter, the company reported loss from operations of $346,994, income from continuing operations before income taxes of $457,113, net income from continuing operations of $454,363 or $0.06 diluted per share, net income of $459,338 or $0.06 diluted per share on net sales of $4,122,059 against loss from operations of $1,157,302, loss from continuing operations before income taxes of $654,915, net income from continuing operations of $657,244 or $0.09 diluted per share, net income of $653,769 or $0.09 diluted per share on net sales of $3,474,231 for the same period a year ago. The increase in revenue was attributable to a 31% increase in BoneScalpel revenue to $2.1 million, a 13% increase in SonaStar revenue to $1.2 million and a 1% increase in SonicOne revenue to $536,000. For the six months, the company reported loss from operations of $2,139,773, loss from continuing operations before income taxes of $429,114, net loss from continuing operations of $434,614 or $0.06 diluted per share, net income of $424,664 or $0.06 diluted per share on net sales of $7,197,643 against loss from operations of $1,328,703, loss from continuing operations before income taxes of $614,899, net income from continuing operations of $618,728 or $0.09 diluted per share, net income of $608,935 or $0.09 diluted per share on net sales of $8,044,756 for the same period a year ago. The decrease in revenue was principally attributable to a decrease of approximately $248,000 in BoneScalpel revenue, a $24,000 decrease in SonicOne revenue and a $302,000 decrease in SonaStar revenue.

Misonix Inc. to Report Q2, 2014 Results on Feb 05, 2014

Misonix Inc. announced that they will report Q2, 2014 results at 8:05 PM, US Eastern Standard Time on Feb 05, 2014

Misonix Inc., Q2 2014 Earnings Call, Feb 05, 2014

Misonix Inc., Q2 2014 Earnings Call, Feb 05, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSON:US $6.14 USD +0.198

MSON Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Integra LifeSciences Holdings Corp $45.30 USD -0.22
Johnson & Johnson $98.96 USD +0.21
Stryker Corp $78.78 USD -0.27
View Industry Companies
 

Industry Analysis

MSON

Industry Average

Valuation MSON Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.2x
Price/Book 3.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.8x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MISONIX INC, please visit www.misonix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.